Department of Biology and Biochemistry, University of Houston, Houston, Texas
Received 13 January 2004/ Returned for modification 10 February 2004/ Accepted 22 June 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Proteins identified to date that are secreted by the type V pathway are virulence factors, and although their ß-domains are highly conserved, their passenger domains can function as adhesins, proteases, hemagglutinins, toxins, or mediators of intracellular motility, depending on the particular niche occupied by the pathogen (18, 24). The serine protease autotransporters of the Enterobacteriaceae (SPATEs) are good examples of the autotransporter family. These molecules are characterized by a conserved serine protease motif, GDSGS, located in their passenger domains (8, 18, 19, 27). The first serine represents the catalytic site (1), and the presence of conserved histidine and aspartate residues has proven essential for protease activity (12). They have a high degree of sequence homology, ranging between 40 and 58% identity (18). Phylogenetic analyses indicate that their passenger domains have a common ancestral root (3). However, their proteolytic specificities differ significantly and are in each case limited to a narrow substrate spectrum (8). Several SPATE proteins have been identified to date, such as the Shigella extracellular protein A (SepA) (3) and the protein involved in intestinal colonization (Pic) (17) proteins from Shigella flexneri; the secreted autotransporter toxin (Sat) from uropathogenic Escherichia coli strains (14); enteropathogenic E. coli secreted protein C (EspC) (37) and E. coli secreted protein P (EspP) (5) from enteropathogenic and enterohemorrhagic E. coli, respectively; the plasmid-encoded toxin (Pet) from enteroaggregative E. coli (11); and the temperature-sensitive hemagglutinin (Tsh) from avian-pathogenic E. coli (APEC) and uropathogenic E. coli (15, 32). All of these proteins are involved in the virulence of the bacterium, although the exact mechanism of their action and contribution to disease development still remain vague (18). Some of the SPATEs, such as EspC, EspP, Sat, and Pet, have been reported to function as cytotoxins on different types of cells (8, 14, 25). EspC and Pet have also been found to cleave spectrin, pepsin, and human coagulation factor V (8, 39). The last two substrates are proteolytically processed by EspP as well (5). Sat, on the other hand, cleaves spectrin and human coagulation factor V (8), whereas Pic displays mucinolytic activity (8, 17).
Tsh was the first SPATE to be described (32) and has served as a model for the study of the secretion and function of these proteins. Tsh is secreted by strains of APEC and is primarily responsible for infections that cause agglutination of bird erythrocytes, leading to airsacculitis and colisepticemia (7, 32). It is synthesized as a 140-kDa precursor that undergoes cleavage of its 52-amino-acid signal sequence in the periplasm. As a next step, the 33-kDa C-terminal domain (residues 1101 to 1377 of the pro-protein) inserts into the outer membrane to mediate translocation of the passenger domain to the cell exterior. Once surface localized, the secreted 106-kDa domain (residues 53 to 1100 of the precursor) remains temporarily bound to the cell envelope, possibly mediating adherence during the early stages of infection, before it is released into the extracellular environment (36). It was recently reported that uropathogenic E. coli also secretes a Tsh autotransporter protein (15).
The reported hemagglutination activity of Tsh, along with the presence of the serine protease motif within its sequence, led us to the hypothesis that Tsh may be a bifunctional protein with both adhesive and proteolytic activities. In the present study, we show that purified Tshs binds with high affinity to red blood cells (RBCs), consistent with its ability to agglutinate RBCs. We demonstrate that it can also adhere to purified hemoglobin, in agreement with the high degree of homology between Tsh and E. coli Hbp hemoglobinase. Furthermore, our results indicate that Tshs binds with great efficiency to extracellular matrix proteins. In addition, we show that serine 259, which corresponds to the first serine of the proteolytic motif, is essential for substrate cleavage but does not affect significantly the protein's binding ability.
| MATERIALS AND METHODS |
|---|
|
|
|---|
6212/pYA232/pYA3551 (6) expressing the functional Tsh protein. The mutagenized Tsh that contains an alanine in place of the serine-259 of the putative active site was purified from the recombinant E. coli RW193/pYA3432 strain (36). Plasmid pYA3551 was constructed by inserting the 4.2-kb EcoRI-BamHI fragment that corresponds to the tsh gene from plasmid pYA3418 (36) into the EcoRI-BamHI restriction sites of the pYA3332 plasmid (provided by Roy Curtiss III, Washington University). E. coli strains were grown in Luria broth medium at 37°C. The antibiotic concentrations used were 10 µg of tetracycline per ml and 100 µg of ampicillin per ml.
Protein purification.
E. coli strains
6212/pYA232/pYA3551 and RW193/pYA3432 expressing wild-type Tshs and Tshs that has serine-259 mutated to alanine (TshsS259A) respectively, were grown overnight at 37°C in 5 ml of Luria broth medium containing tetracycline in the first case and ampicillin in the second case. Each culture was transferred in 1 liter of fresh Luria broth medium with the appropriate antibiotic and incubated at 37°C. At an optical density of 0.6 at 600 nm, synthesis of Tsh was induced for 3 h by the addition of 0.5 mM isopropyl-ß-D-thiogalactopyranoside (IPTG). The culture supernatant was collected after centrifugation (Beckman J2-21M centrifuge, rotor JA-10) at 4,000 rpm for 30 min (all centrifugation steps were carried out at 4°C) and subjected to ammonium sulfate precipitation. At a concentration of 60% of 3.8 M (NH4)2SO4, wild-type and mutated Tshs were precipitated by centrifugation in the J2-21M centrifuge at 9,000 rpm for 30 min. The pellet was dissolved in 5 ml of 20 mM Tris-HCl buffer (pH 8.0) and dialyzed against the same buffer by using 10,000-molecular-weight-cutoff dialysis cassettes (Pierce, Rockford, Ill.). The protein concentration of the obtained Tsh-containing sample was measured by the Bradford assay. The protein sample (0.423 mg/ml) was centrifuged (Eppendorf 5417R centrifuge, rotor F45-30-11) at 10,000 x g for 10 min and applied to a 5-ml Hitrap Q Fast Flow anion-exchange column (Amersham Biosciences Corp., Piscataway, N.J.), equilibrated with 20 mM Tris-HCl buffer (pH 8.0). Proteins were eluted using a linear ionic strength gradient ranging from 5 mM to 1 M NaCl, and their presence was monitored by observing the optical density at 280 nm. The flow rate was 1 ml/min, and 4-ml fractions were collected. Proteins were visualized by silver staining after separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10% polyacrylamide). Estimation of the protein purity and yield was carried out by densitometric analysis, using ImageJ software (http://rsb.info.nih.gov/ij/).
Enzyme-linked immunosorbent assay (ELISA) with RBCs. Sheep RBCs (Sigma, St. Louis, Mo.) were coated onto a 96-well plate in a dilution of 1:50 in phosphate-buffered saline (PBS). Fifty microliters of purified Tshs or TshsS259A, each diluted in 20 mM Tris-HCl (pH 8.0) to a final concentration of 10 µg/ml, was added to separate wells, and the plate was incubated for 3 h at 37°C. Unbound protein was washed away with PBS, and 50 µl of rabbit anti-Tsh antibody was added to each well, diluted 1:2,000 in PBS containing 0.2% bovine serum albumin (BSA). Incubation was carried out for 2 h at 37°C. A secondary anti-rabbit immunoglobulin G (IgG) antibody conjugated to alkaline phosphatase (Sigma) was used at a dilution of 1:10,000 in PBS-0.2% BSA. The reaction took place for 1 h at 37°C. After the final wash, binding was detected by incubating wells with 100 µl of an alkaline phosphatase substrate solution (Pierce). The reaction was stopped with 100 µl of 2 N NaOH. The absorbance was measured at 405 nm, and the data were analyzed by Softmax software version 2.02. Three independent experiments were performed, with four wells for every reaction in each experiment, and the results were averaged. Reactions in which the same amount of bovine serum albumin (Sigma) was incubated with the RBCs along with reactions that consisted of buffer incubated with the erythrocytes and reactions that had not undergone the primary antibody incubation step were used as negative controls. Buffer was used to blank the spectrophotometer, and the measured background value was subtracted from the presented results.
ELISA with proteins. BSA, bovine mucin, and turkey hemoglobin (Sigma) prepared at a concentration of 50 µg/ml in PBS were coated onto separate wells of a 96-well plate. The wells were blocked with 150 µl of PBS-0.25% BSA-0.05% Tween 20 for 1 h at 37°C. Then 100 µl of Tshs diluted in PBS to a final concentration of 100 µg/ml was added to each well, and the wells were incubated for 1 h at 37°C. After being washed three times with PBS-0.5% Tween 20, the wells were incubated for 1 h at 37°C with 100 µl of rabbit anti-Tsh antibody in a dilution of 1:3,000 in PBS-0.25% BSA-0.05% Tween 20. A secondary anti-rabbit IgG antibody conjugated to horseradish peroxidase (Bio-Rad Laboratories, Inc., Hercules, Calif.) was added to each well, diluted 1:20,000 in PBS-0.25% BSA-0.05% Tween 20. Incubation was carried out for 1 h at 37°C. Substrate solution for horseradish peroxidase (Pierce) was used for 30 min at room temperature to estimate binding. The reaction was stopped by addition of 1 M H2SO4, and absorbance was measured at 450 nm. Data were analyzed by Softmax software version 2.02. Three independent experiments were performed, with four wells for every reaction in each experiment, and the values obtained were averaged. The negative control was set by using PBS-0.25% BSA-0.05% Tween 20 instead of Tshs to incubate with the subject proteins. Buffer was used to blank the spectrophotometer, and the blank was subtracted from the presented values.
ELISA with ECM proteins. Adherence of Tshs to collagen IV (mouse), fibronectin (human), and laminin (mouse) was measured by using 96-well plates coated with the subject ECM proteins, obtained from BD Biosciences (Bedford, Mass.). The blocking step was performed for 1 h at room temperature with 200 µl of PBS-0.2% BSA in each well. The wells were washed twice with PBS and incubated with 100 µl of purified Tshs diluted in 20 mM Tris-HCl (pH 8.0) to final concentrations of 100, 50, 10, 1, and 0.5 µg/ml, for 2 h at 37°C. Unbound protein was washed away with PBS, and 100 µl of rabbit anti-Tsh antibody diluted 1:2,000 in PBS-0.2% BSA was added to each well. The plate was incubated for 2 h at 37°C, and excess antibody was washed away with PBS. A 100-µl volume of anti-rabbit IgG antibody conjugated to horseradish peroxidase (Pierce) was added to each well at a dilution of 1:10,000 in PBS-0.2% BSA. Incubation was carried out for 1 h at 37°C. The wells were washed three times with PBS and incubated with 200 µl of horseradish peroxidase substrate solution (Pierce). After oxidation with 150 µl of 1 M H2SO4, absorbance was measured at 450 nm. Data were analyzed by using Softmax software version 2.02. BSA (100 µg/ml) incubated with the ECM proteins in place of Tshs was used as a negative control. Reactions that had not undergone the primary antibody incubation step were used to ensure that there was no cross-reaction of the secondary antibody. Three independent experiments were carried out with each reaction in triplicate, and the measured values were averaged. Buffer was used to blank the spectrophotometer, and the measured background was subtracted from the presented values.
Proteolytic assay. Proteolytic activity was detected using a casein derivative that is heavily labeled with the pH-insensitive green fluorescent BODIPY FL dye (Molecular Probes Inc., Eugene, Oreg.) as a substrate. Proteolytic cleavage of casein releases fluorescent-labeled peptides, and the increase in green fluorescence can be measured in a microplate reader. Trypsin (Sigma) and purified Tshs (15 µg each), each diluted in a digestion buffer consisting of 10 mM Bis-Tris (pH 6.0) to a final volume of 100 µl, were added to separate triplicate wells of a 96-well plate. Then 100 µl of casein substrate prepared at 10 µg/ml in digestion buffer was added to each well. Incubation was carried out at 37°C for 16 h, with the samples protected from light. Fluorescence was measured in microplate fluorometer FLX800 from Bio-Tec (St. Louis, Mo.) with standard fluorescein filters (excitation, 485 ± 20 nm; emission, 528 ± 20 nm). Data were analyzed using KC4 software version 3.0. Reactions in which casein was incubated with digestion buffer were used as a negative control. Three independent experiments were carried out, with three wells for every reaction in each experiment, and the values presented correspond to the means, with the background measurement subtracted.
Bioinformatic analyses. The protein domains of Tshs were analyzed using the 3D-PSSM folding recognition algorithm (www.sbg.bio.ic.ac.uk).
Statistical analyses. Data are presented as mean values with a 95% confidence interval. The different test groups were compared by a one-way analysis of variance, followed by pairwise comparisons using Tukey's honest significant difference test. Data were log-transformed to correct for heterogeneity of the variances where necessary. The Student t test was used when comparing only two groups, as is the case for the ELISA with hemoglobin, mucin, and BSA. A P value below 5% was considered indicative of statistical significance. Analyses were performed using the R software (http://cran.stat.ucla.edu/).
| RESULTS |
|---|
|
|
|---|
6212/pYA232/pYA3551 strain could interact with RBCs in an ELISA. Tshs was isolated from the secreted proteins by ammonium sulfate precipitation and anion-exchange chromatography with a linear gradient of increasing ionic strength (Fig. 1). The protein purity corresponded to 96%, with one contaminant (less than 4% of the total protein) of approximately 30 kDa, which most probably does not represent product of proteolytic cleavage, since it does not react with anti-Tsh antibody (data not shown). The insignificant amount of this smaller protein compared to the high concentration of Tshs makes it highly impossible that this protein could interfere with the observed results. The recovered Tshs in the pure fraction was estimated to be 55% of the total Tshs in the unpurified sample, a significant yield for such a high percentage of purity. This fraction of purified Tshs was used for incubation with sheep RBCs coated onto a 96-well flat-bottom plate. Binding was monitored with a polyclonal antiserum raised against Tshs. The obtained values revealed a significant degree of adhesion of Tshs to the RBCs compared to the negative control, which consisted of RBCs incubated with buffer instead of protein (Fig. 2). No appreciable binding was measured for BSA, which was used as an additional negative control. Reactions that lacked primary anti-Tsh antibody were set up to ensure that there was no cross-reaction of the secondary antibody. The results indicate that Tshs is an adhesin that retains its binding ability even after release from the bacterial cell.
|
|
|
Purified Tshs cleaves casein, and serine-259 is required for its proteolytic activity. It has been previously reported that autotransporters possessing a serine protease motif exhibit protease activity, which is restricted to a limited number of substrates in each case (8). We assayed Tshs for its ability to cleave casein and tested the role of serine-259, the first serine of the motif in Tsh, as a putative proteolytically active site. Purified Tshs was incubated overnight with a highly fluorescent casein substrate. Trypsin, a well-known serine protease with a great variety of reported substrates including casein, was used as a positive control in the assay. Measurements of the released fluorescence revealed a high degree of casein cleavage by Tshs compared to that of trypsin (Fig. 4). Thus, casein is a protein substrate of Tshs and particularly one that is cleaved by Tshs with high efficiency.
|
TshsS259A can function as an adhesin. The fact that serine-259 is essential for the proteolytic activity of Tshs prompted us to test if this residue is also required for the adhesive function of the protein. Purified TshsS259A was screened for its ability to bind to RBCs in an ELISA. Reaction mixtures containing wild-type Tshs incubated with the RBCs were included as a positive control. Strong binding was measured for the mutated protein compared to the wild-type one, as shown in Fig. 2. This shows that serine-259 is not required for adhesion to host cells and that its absence does not significantly affect the binding interaction. These data suggest that the site required for adherence may be independent of the site responsible for proteolytic activity of Tshs.
To further extend these findings, we tested for the effects of mutated serine-259 on the adherence of Tshs to ECM proteins. TshsS259A was incubated with collagen IV and fibronectin under the same conditions as the ones used for wild-type Tshs (Fig. 3B and C, lanes F). The obtained measurements indicate that the mutagenized Tshs can still bind to both fibronectin and collagen IV but that the strength of the observed binding interaction is decreased. These results are in good agreement with the ones presented above and further strengthen the assumption that the adhesive and proteolytic functions of Tshs lie in different domains of the protein.
| DISCUSSION |
|---|
|
|
|---|
Tsh is synthesized as a 140-kDa precursor protein composed of a cleavable N-terminal signal peptide, a 106-kDa passenger domain, and a 33-kDa C-terminal domain (36). It was initially reported as a hemagglutinin for avian erythrocytes, acting in a temperature-dependent manner and while still in contact with the bacterial surface (32, 36). This function suggested that Tsh might be a putative adhesin that mediates colonization of the respiratory tract by the bacterial pathogen during the early stages of infection, a hypothesis that was further supported by the results of in vivo infection studies (7). The latter demonstrated that Tsh is responsible for the development of lesions and deposition of fibrin in the avian air sacs and also showed that its presence accelarates the progression of the infection (7). Furthermore, although the optimal temperature for the hemagglutination activity of Tsh is 26°C (32), the protein is still present at higher temperatures, implying that it may play multiple roles in the infectious process (36).
We performed in vitro studies to assess the ability of Tsh to act as an adhesin. Since the main function of an autotransporter is carried out by its passenger domain (18, 19, 24, 27), we tested purified Tshs for binding to RBCs in an ELISA. The obtained results are in good agreement with the previously reported hemagglutination activity of the surface-localized Tsh (32) and indicate that the secreted protein domain itself is sufficient for adherence to the RBCs. Furthermore, these data demonstrate that Tshs remains in a binding-competent state even after release to the extracellular medium. This suggests that Tshs contributes to disease development not only while still on the bacterial surface but even after being secreted to the external environment, which implies that the protein may be important for later stages of the infection as well.
To extend these findings, we looked for binding interactions of Tshs with substrates that could be putative targets, with the aim of elucidating the mechanism of action of Tsh and its link to APEC pathogenicity. Earlier studies identified an autotransporter protein from pathogenic E. coli strain EB1 that is identical to Tsh in terms of sequence, with the exception of two amino acid residues at positions 209 and 842. This close Tsh homologue, known as Hbp, was reported to degrade hemoglobin and bind its heme portion (30). The high degree of homology between Tsh and Hbp, along with the previously reported hemagglutination activity of Tsh (32), prompted us to test Tshs for its ability to adhere to hemoglobin. We observed a strong binding interaction, indicative of efficient adherence of Tshs to hemoglobin. Taking into consideration that Tshs is also capable of interacting with the RBCs, these data could suggest that upon binding to the erythrocytes, the protein enters the cells and gains access to hemoglobin. Alternatively, binding of Tshs to hemoglobin may take place after release of the latter to the extracellular medium due to erythrocyte lysis, which might involve the proteolytic properties of Tshs (see below) as well. Further studies need to be carried out to gain a better understanding of the in vivo effects of these binding interactions. We also tested for interactions of Tshs with mucin, since Tsh is secreted by a bacterium that invades the mucosal surface. In this case, however, the obtained signal corresponded to insignificant adherence under the conditions tested.
To gain a better insight into the virulence of Tsh, we screened for its ability to adhere to ECM proteins. These proteins are closely associated with endothelial and epithelial cells and form a mesh that functions not only to mechanically support the tissues but also to protect them against bacterial invasion (29, 33, 40). ECM components constitute binding targets for many bacterial pathogens, such as streptococci, staphylococci, enterococci, and yersiniae, and interaction with these host compounds is crucial for the infection process (9, 22, 26, 34). It has been previously shown that Hap, an adhesive autotransporter secreted by Haemophilus influenzae (21), is also capable of binding with high affinity to selected components of the ECM (13). The fact that Hap is closely related to Tsh in terms of sequence homology provided further motivation for examining interactions between Tsh and major ECM proteins of the respiratory epithelium, such as collagen IV, fibronectin, and laminin (13, 33). The binding assays revealed a strong binding interaction of purified Tshs with fibronectin and collagen IV. These data suggest an involvement of Tsh in colonization of the host respiratory tract by APEC strains. Adherence to the host cells enables the microorganism to withstand mechanical defense responses generated by the immune response system. Therefore, Tsh may play a critical role in the early stages of infection. Given that Tshs is a serine protease (see below), it is also possible that adherence to the ECM proteins is followed by their degradation, permitting the bacterium to penetrate to deeper host tissue compartments and thus enhancing bacterial dispersal and protection against immune responses. Further studies need to be carried out before we can gain a better understanding of the adherence properties of the protein in the infection process.
The presence of a serine protease motif, GDSGSPL, within the passenger domain of Tsh (32) prompted us to study the proteolytic activity of the protein. This motif is conserved among many reported proteases of the autotransporter family, such as IgA proteases from Neisseria gonorrhoeae and Haemophilus influenzae (31), Hap from H. influenzae (20), and the SPATEs, a subfamily of autotransporters secreted by the Enterobacteriaceae (18). The first serine of this motif is the putative active site, and its substitution renders the enzyme inactive (1, 31). Two additional residues, a conserved histidine and aspartate, are also important for proteolytic activity (12). Sequence alignments revealed that these three residues, in the case of Tsh, correspond to S259, H124, and D152. Despite the homology between the secreted domain of Tsh and that of IgA protease, the two proteins do not seem to have the same substrate specificity, since Tshs cannot cleave human or chicken IgA (36). Furthermore, Tsh does not require the serine protease motif for procession and secretion of the surface localized mature protein (36), in contrast to both IgA and Hap, which employ an autoproteolytic mechanism for release to the extracellular milieu (20).
Recent studies showed that Tshs exhibits mucinolytic activity (8). In the present study, we show that Tshs can cleave casein, providing further evidence for its proteolytic function. We also demonstrate that serine-259 is absolutely required for enzymatic activity since the latter is abolished when this residue is replaced by alanine. Taken together, these results demonstrate that Tsh is a typical serine protease, with the first serine of the GDSGSPL motif being the catalytically active site. Further studies need to be carried out to clarify how the proteolytic activity is linked to the pathogenicity of the host bacterium.
The results presented above indicate that the passenger domain of Tsh is a bifunctional protein that can act both as an adhesin and as a protease. We sought to determine whether the two functions of Tshs are related or carried out independently. We have demonstrated that serine-259 is indispensable for the proteolytic function of Tshs. We have also investigated whether this residue is required for the adhesin properties of Tshs as well. Our findings show that absence of serine-259 does not annul the ability of the protein to bind to its substrates, and thus this residue, although critical for the proteolytic activity, is not crucial for the binding interactions of Tshs. From these results, it appears that the proteolytic and adhesive functions of Tshs are carried out by distinct domains of the protein and do not depend on each other. However, a decrease in the binding efficiency is observed for TshsS259A, implying that substitution of serine-259 may have affected the ability of the protein to fold properly, resulting in a slightly altered binding pocket that can still recognize and adhere to its targets but with reduced affinity. Future work is needed to verify whether these two functions of Tshs are indeed independent.
Analysis using the 3D-PSSM folding recognition algorithm (23) indicates the presence of two distinct structural domains within the Tshs sequence. (i) The first domain corresponds to the amino-terminal moiety of Tshs (residues 53 to 708) and has structural similarity to the C-terminal domain of the alkaline protease of Pseudomonas aeruginosa (2). (ii) The second domain corresponds to the carboxy-terminal moiety of Tshs (residues 709 to 1100) and has structural similarity to the Bordetella pertussis P.69 adhesin (10). The structures of both the P. aeruginosa alkaline protease and the B. pertussis P.69 adhesin are characterized by the extended presence of ß-strand conformation. The C-terminal domain of P. aeruginosa alkaline protease consists of a 21-strand ß-sandwich. The P.69 adhesin, the only autotransporter with a solved crystal structure (10), folds into a novel 16-strand parallel ß-helix with a V-shaped cross section and represents the largest ß-helix known to date. Interestingly, the carboxyl-terminal moiety of Tshs that has structural similarity to the P.69 adhesin does not include a 90-amino-acid sequence that has been shown to be necessary for folding of the passenger domain in several other autotransporters (28). It will be interesting to determine whether the amino- and carboxy-terminal domains of Tshs can function independently of each other when they are not linked in the same polypeptide. Further studies are under way in our laboratory to determine the structure-function relationship in the Tsh autotransporter protein.
| ACKNOWLEDGMENTS |
|---|
This study was supported by a Welch Foundation Award (E-1548) and a research grant from the U.S. Department of Agriculture.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Bachovchin, W. W., A. G. Plaut, G. R. Flentke, M. Lynch, and C. A. Kettner. 1990. Inhibition of IgA1 proteinases from Neisseria gonorrhoeae and Haemophilus influenzae by peptide prolyl boronic acids. J. Biol. Chem. 265:3738-3743. |
| 2. | Baumann, U., S. Wu, K. M. Flaherty, and D. B. McKay. 1993. Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J. 12:3357-3364.[Medline] |
| 3. | Benjelloun-Touimi, Z., M. S. Tahar, C. Montecucco, P. J. Sansonetti, and C. Parsot. 1998. SepA, the 110 kDa protein secreted by Shigella flexneri: two-domain structure and proteolytic activity. Microbiology 144:1815-1822. |
| 4. | Brown, P. K., and R. Curtiss III. 1996. Unique chromosomal regions associated with virulence of an avian pathogenic Escherichia coli strain. Proc. Natl. Acad. Sci. USA 93:11149-11154. |
| 5. | Brunder, W., H. Schmidt, and H. Karch. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7, cleaves human coagulation factor V. Mol. Microbiol. 24:767-778.[CrossRef][Medline] |
| 6. | Curtiss, R., III, J. E. Galan, K. Nakayama, and S. M. Kelly. 1990. Stabilization of recombinant avirulent vaccine strains in vivo. Res. Microbiol. 141:797-805.[Medline] |
| 7. | Dozois, C. M., M. Dho-Moulin, A. Bree, J. M. Fairbrother, C. Desautels, and R. Curtiss III. 2000. Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the Tsh genetic region. Infect. Immun. 68:4145-4154. |
| 8. | Dutta, P. R., R. Cappello, F. Navarro-Garcia, and J. P. Nataro. 2002. Functional comparison of serine protease autotransporters of Enterobacteriaceae. Infect. Immun. 70:7105-7113. |
| 9. | El Tahir, Y., and M. Skurnik. 2001. YadA, the multifaceted Yersinia adhesin. Int. J. Med. Microbiol. 291:209-218.[CrossRef][Medline] |
| 10. | Emsley, P., I. G. Charles, N. F. Fairweather, and N. W. Isaacs. 1996. Structure of Bordetella pertussis virulence factor P.69 pertactin. Nature 381:90-92.[CrossRef][Medline] |
| 11. | Eslava, C., F. Navarro-Garcia, J. R. Czeczulin, I. R. Henderson, A. Cravioto, and J. P. Nataro. 1998. Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli. Infect. Immun. 66:3155-3163. |
| 12. | Fink, D. L., L. D. Cope, E. J. Hansen, and J. W. St. Geme III. 2001. The Haemophilus influenzae Hap autotransporter is a chymotrypsin clan serine protease and undergoes autoproteolysis via an intermolecular mechanism. J. Biol. Chem. 276:39492-39500. |
| 13. | Fink, D. L., B. A. Green, and J. W. St. Geme III. 2002. The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV. Infect. Immun. 70:4902-4907. |
| 14. | Guyer, D. M., I. R. Henderson, J. P. Nataro, and H. L. Mobley. 2000. Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli. Mol. Microbiol. 38:53-66.[CrossRef][Medline] |
| 15. | Helmer, S. R., D. A. Rasko, C. V. Lockatell, D. E. Johnson, and H. L. Mobley. 2004. Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect. Immun. 72:593-597. |
| 16. | Henderson, I. R., R. Cappello, and J. P. Nataro. 2000. Autotransporter proteins, evolution and redefining protein secretion. Trends Microbiol. 8:529-532.[CrossRef][Medline] |
| 17. | Henderson, I. R., J. Czeczulin, C. Eslava, F. Noriega, and J. P. Nataro. 1999. Characterization of Pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect. Immun. 67:5587-5596. |
| 18. | Henderson, I. R., and J. P. Nataro. 2001. Virulence functions of autotransporter proteins. Infect. Immun. 69:1231-1243. |
| 19. | Henderson, I. R., F. Navarro-Garcia, and J. P. Nataro. 1998. The great escape: structure and function of the autotransporter proteins. Trends Microbiol. 6:370-378.[CrossRef][Medline] |
| 20. | Hendrixson, D. R., M. L. de la Morena, C. Stathopoulos, and J. W. St. Geme III. 1997. Structural determinants of processing and secretion of the Haemophilus influenzae Hap protein. Mol. Microbiol. 26:505-518.[CrossRef][Medline] |
| 21. | Hendrixson, D. R., and J. W. St. Geme III. 1998. The Haemophilus influenzae Hap serine protease promotes adherence and microcolony formation, potentiated by a soluble host protein. Mol. Cell 2:841-850.[CrossRef][Medline] |
| 22. | Hussain, M., K. Becker, C. von Eiff, J. Schrenzel, G. Peters, and M. Herrmann. 2001. Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J. Bacteriol. 183:6778-6786. |
| 23. | Kelley, L. A., R. M. MacCallum, and M. J. Sternberg. 2000. Enhanced genome annotation using structural profiles in the program 3D-PSSM. J. Mol. Biol. 299:499-520.[Medline] |
| 24. | Loveless, B. J., and M. H. Saier, Jr. 1997. A novel family of channel-forming, autotransporting, bacterial virulence factors. Mol. Membr. Biol. 14:113-123.[Medline] |
| 25. | Mellies, J. L., F. Navarro-Garcia, I. Okeke, J. Frederickson, J. P. Nataro, and J. B. Kaper. 2001. espC pathogenicity island of enteropathogenic Escherichia coli encodes an enterotoxin. Infect. Immun. 69:315-324. |
| 26. | Nallapareddy, S. R., X. Qin, G. M. Weinstock, M. Hook, and B. E. Murray. 2000. Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I. Infect. Immun. 68:5218-5224. |
| 27. | Newman, C., and C. Stathopoulos. Autotransporter and two-partner secretion: delivery of large-size virulence factors by gram-negative bacterial pathogens. Crit. Rev. Microbiol, in press. |
| 28. | Oliver, D. C., G. Huang, E. Nodel, S. Pleasance, and R. C. Fernandez. 2003. A conserved region within the Bordetella pertussis autotransporter BrkA is necessary for folding of its passenger domain. Mol. Microbiol. 47:1367-1383.[CrossRef][Medline] |
| 29. | Ortega, N., and Z. Werb. 2002. New functional roles for non-collagenous domains of basement membrane collagens. J. Cell Sci. 115:4201-4214. |
| 30. | Otto, B. R., S. J. van Dooren, J. H. Nuijens, J. Luirink, and B. Oudega. 1998. Characterization of a hemoglobin protease secreted by the pathogenic Escherichia coli strain EB1. J. Exp. Med. 188:1091-1103. |
| 31. | Poulsen, K., J. Reinholdt, and M. Kilian. 1992. A comparative genetic study of serologically distinct Haemophilus influenzae type 1 immunoglobulin A1 proteases. J. Bacteriol. 174:2913-2921. |
| 32. | Provence, D. L., and R. Curtiss III. 1994. Isolation and characterization of a gene involved in hemagglutination by an avian pathogenic Escherichia coli strain. Infect. Immun. 62:1369-1380. |
| 33. | Roman, J. 1996. Extracellular matrix and lung inflammation. Immunol. Res. 15:163-178.[Medline] |
| 34. | Spellerberg, B., E. Rozdzinski, S. Martin, J. Weber-Heynemann, N. Schnitzler, R. Lutticken, and A. Podbielski. 1999. Lmb, a protein with similarities to the Lral adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect. Immun. 67:871-878. |
| 35. | Stathopoulos, C., D. R. Hendrixson, D. G. Thanassi, S. J. Hultgren, J. W. St. Geme III, and R. Curtiss III. 2000. Secretion of virulence determinants by the general secretory pathway in gram-negative pathogens: an evolving story. Microbes Infect. 2:1061-1072.[CrossRef][Medline] |
| 36. | Stathopoulos, C., D. L. Provence, and R. Curtiss III. 1999. Characterization of the avian pathogenic Escherichia coli hemagglutinin Tsh, a member of the immunoglobulin A protease-type family of autotransporters. Infect. Immun. 67:772-781. |
| 37. | Stein, M., B. Kenny, M. A. Stein, and B. B. Finlay. 1996. Characterization of EspC, a 110-kilodalton protein secreted by enteropathogenic Escherichia coli which is homologous to members of the immunoglobulin A protease-like family of secreted proteins. J. Bacteriol. 178:6546-6554. |
| 38. | Thanassi, D. G., and S. J. Hultgren. 2000. Multiple pathways allow protein secretion across the bacterial outer membrane. Curr. Opin. Cell Biol. 12:420-430.[CrossRef][Medline] |
| 39. | Villaseca, J. M., F. Navarro-Garcia, G. Mendoza-Hernandez, J. P. Nataro, A. Cravioto, and C. Eslava. 2000. Pet toxin from enteroaggregative Escherichia coli produces cellular damage associated with fodrin disruption. Infect. Immun. 68:5920-5927. |
| 40. | Westerlund, B., and T. K. Korhonen. 1993. Bacterial proteins binding to the mammalian extracellular matrix. Mol. Microbiol. 9:687-694.[Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|